(Q53677088)

17 May 2018

title

A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. (English)

1 reference

17 May 2018

0 references

14

1 reference

17 May 2018

Louis-Philippe Boulet

2

object named as

Louis-Philippe Boulet

1 reference

17 May 2018

Gail M Gauvreau

1

1 reference

17 May 2018

Richard Leigh

3

1 reference

17 May 2018

Donald W Cockcroft

4

1 reference

17 May 2018

Kieran J Killian

5

1 reference

17 May 2018

Beth E Davis

6

1 reference

17 May 2018

Francine Deschesnes

7

1 reference

17 May 2018

Richard M Watson

8

1 reference

17 May 2018

Veronica Swystun

9

1 reference

17 May 2018

Carina Kärrman Mårdh

10

1 reference

17 May 2018

Peter Wessman

11

1 reference

17 May 2018

Carin Jorup

12

1 reference

17 May 2018

Magnus Aurivillius

13

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 January 2015

1 reference

17 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

17 May 2018

volume

191

1 reference

17 May 2018

issue

2

1 reference

17 May 2018

page(s)

161-167

1 reference

17 May 2018

Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Anti-inflammatory functions of glucocorticoid-induced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Anti-inflammatory glucocorticoids: changing concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Inhaled allergen bronchoprovocation tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

21 January 2018

Late asthmatic responses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Effects of montelukast and budesonide on airway responses and airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Systemic effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201404-0623OC

10.1164/RCCM.201404-0623OC

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018